tga bpc-157 scheduling australia The has added illegal peptides to its 2026 compliance priorities as concerns grow about their use for performance and anti-ageing. Experts warn these unapproved products may carry serious safety risks, especially As illegal peptide use in
As illegal peptide use in Australia continues to skyrocket, the TGA has formally deemed it such a risk to consumer safety it has made it a compliance priority for 2026 warning Best BPC 157 Australia Supplier Melanotan AUS Since January 2026, there have been six cases of acute liver toxicity associated with unapproved peptide products labelled Retatrutide in Australia. These toxic effects may be linked to a contaminant in the TGA Regulation Amendments ACTA Australian Clinical Trials Alliance
Pay in 4 interest-free payments of $5.93 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

